Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
BMJ Clinical Evidence
|
February 10, 2016
Headache (chronic tension-type)
Mona Ghadiri-Sani, Nicholas Silver
The Journal of the Royal College of Physicians of Edinburgh
|
December 7, 2019
Head turning sign
Mona Ghadiri-Sani, Andrew J Larner
Molecular and Cellular Neurosciences
|
March 17, 2007
Induced expression of polysialic acid in the spinal cord promotes regeneration of sensory axons
Yi Zhang, Mona Ghadiri-Sani, Xinyu Zhang, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 22, 2024
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Edoardo Caronna, Victor José Gallardo, Gabriella Egeo, et al.
Cephalalgia : an International Journal of Headache
|
June 19, 2026
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort
Edoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
BMJ Clinical Evidence
|
February 10, 2016
Headache (chronic tension-type)
Mona Ghadiri-Sani, Nicholas Silver
The Journal of the Royal College of Physicians of Edinburgh
|
December 7, 2019
Head turning sign
Mona Ghadiri-Sani, Andrew J Larner
Molecular and Cellular Neurosciences
|
March 17, 2007
Induced expression of polysialic acid in the spinal cord promotes regeneration of sensory axons
Yi Zhang, Mona Ghadiri-Sani, Xinyu Zhang, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 22, 2024
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world
Edoardo Caronna, Victor José Gallardo, Gabriella Egeo, et al.
Cephalalgia : an International Journal of Headache
|
June 19, 2026
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort
Edoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Page
of 1